Author: digi

Aligning Privacy Protections With Data Quality and Scientific Value Aligning Privacy Protections With Data Quality and Scientific Value In the landscape of clinical trials, the intersection of privacy rights, data quality, and scientific value is increasingly critical. This guide aims to equip clinical operations, regulatory affairs, and medical affairs professionals with comprehensive knowledge and practical…

Read More “Aligning Privacy Protections With Data Quality and Scientific Value” »

Managing Breaches of Confidentiality: Reporting, CAPA and Communications Managing Breaches of Confidentiality: Reporting, CAPA and Communications In the context of clinical trials, confidentiality is paramount. With sensitive patient information at stake, managing breaches of confidentiality is integral to maintaining integrity and trust in clinical research. This guide provides a step-by-step approach for clinical operations, regulatory…

Read More “Managing Breaches of Confidentiality: Reporting, CAPA and Communications” »

Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls In today’s rapidly evolving landscape of clinical research, understanding the operational requirements and potential pitfalls regarding privacy and confidentiality is paramount. This tutorial provides a detailed, step-by-step guide for clinical operations, regulatory affairs, and medical…

Read More “Privacy and Confidentiality in Clinical Trials: Operational Requirements and Pitfalls” »

Designing De-Identification and Coding Strategies for Participant Data Designing De-Identification and Coding Strategies for Participant Data In the landscape of clinical trials, particularly concerning ovarian cancer clinical trials, ensuring the privacy and confidentiality of participant data is paramount. The ethical handling of such sensitive information not only aligns with regulatory mandates but also fosters trust…

Read More “Designing De-Identification and Coding Strategies for Participant Data” »

Secondary Use of Trial Data and Specimens: Ethics and Regulatory Pathways Introduction The secondary use of trial data and specimens involves utilizing data collected during clinical trials for purposes other than those initially intended. This can facilitate further research, enhance the understanding of diseases, and support public health initiatives. However, these practices introduce complex ethical…

Read More “Secondary Use of Trial Data and Specimens: Ethics and Regulatory Pathways” »

Managing Privacy Risks in Decentralized and Technology-Enabled Trials As the landscape of clinical research evolves, the incorporation of technology and decentralized approaches to clinical trials, also known as nucleus clinical trials, has emerged prominently. However, these innovations bring forth critical challenges around privacy risks, which must be adequately managed to ensure compliance with various regulations…

Read More “Managing Privacy Risks in Decentralized and Technology-Enabled Trials” »

Confidentiality Obligations in Contracts, Protocols and Site Agreements Confidentiality Obligations in Contracts, Protocols and Site Agreements In the highly regulated environment of clinical research, confidentiality is paramount. The obligations surrounding confidentiality are woven into a multitude of documents, including contracts, protocols, and site agreements. This guide aims to provide a comprehensive overview of confidentiality obligations…

Read More “Confidentiality Obligations in Contracts, Protocols and Site Agreements” »